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Objective: To determine the resistance rate to amoxycillin/clavulanate (AMC) in 100 Escherichia coli strains isolated 
from outpatients with urinary tract infection (UTI) in four Greek hospitals and assess the relationship between 
p-lactamase content and resistance t o  AMC. 
Methods: Susceptibility t o  p-lactams was determined with the E-test. Sonic cell extracts were used as p-lactamase 
preparations. Conjugal transfer of resistance was performed in broth cultures. p-Lactamase quantities were evaluated 
by measuring nitrocefin hydrolysis. lsoelectric points (PIS) of p-lactamases were determined by electrofocusing. The 
substrate specificity of the enzymes and the inhibitory activity of clavulanate were studied spectrophotometrically. 
Results: Thirty-two isolates were resistant t o  ampicillin. Eight were resistant (MIC 232 mg/L) and 11 showed decreased 
susceptibility (MIC 4-16 mg/L) to AMC. The latter expressed at least four-fold higher amounts of TEM-1 p-lactamase 
compared with the TEM-1-producing AMC-susceptible isolates. Seven AMC-resistant isolates produced at least 16-fold 
higher amounts of TEM-1; in  one isolate, resistance was attributed to  an OXA-type p-lactamase. None of the AMC- 
resistant isolates was able to transfer resistance t o  AMC by conjugation. Clavulanate-resistant TEM variants were not 
detected. 
Conclusions: Amoxycillin/clavulanate-resistant E. coli strains have become established in the Greek community. 
Resistance is mainly due to  the production of large amounts of TEM-1 p-lactamase which is encoded from non-self- 
transmissible plasmids. 
Key words: fscherichia coli, resistance, p-lactamase, amoxycillin/clavulanate 
INTRODUCTION 
An approach to overcome the hydrolytic inactivation of 
the labile p-lactam antibiotics by bacterial p-lactamases 
is their use in combination with a p-lactamase inhibitor 
such as clavulanic acid [l]. The combination of amoxy- 
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cillin witb clavulanic acid (AMC) is one of the anti- 
biotics most frequently prescribed by Greek general 
practitioners for the treatment of community-acquired 
infections. It is used in the empirical treatment of 
outpatients suffering respiratory tract infections and, 
along with co-trimoxazole, is the antibiotic of choice 
for unconiplicated urinary tract infections caused by 
enterobacteria. 
There have been several studies reporting the 
emergence and dissemination of Escherichia coli iso- 
lates resist,ant to AMC. Resistance has been mostly 
attributed to elevated production of the common 
plasmid-mediated TEM-1 penicillinase [2-41. There 
is also an increasing number of studies noting the 
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emergence of TEM [5,6], OHIO-1 [7] and SHV vari- 
ants [8] not inhibited by clinically achievable concen- 
trations of clavulanate. Other mechanisms, including 
the expression of OXA-type p-lactamases [9,10] and 
decreased outer membrane permeability [ l l ] ,  have also 
been reported. 
In this work, we determined the frequency of 
resistance to AMC in a representative sample of E. coli 
isolates derived from outpatients who attended four 
general hospitals in Greece. To analyze the mechanisms 
of resistance to AMC, we determined the susceptibility 
of the isolates to selected p-lactams and assessed their 
p-lactamase content. 
MATERIALS AND METHODS 
Bacterial strains 
In total, 100 non-repetitive E. coli isolates were 
included in the study. They were derived from urine 
cultures from outpatients attending three general 
hospitals located in the Athens area and the University 
Hospital of Heraklion, Crete, during October- 
December 1996. Isolates derived from patients who 
had been hospitalized in 1996 were excluded. The 
strains were identified with API20E (API BioMerieux, 
La Balme les Grottes, France). 
Susceptibility testing and transfer of resistance to 
amoxycillin/clavulanate 
The initial assessment of the susceptibility status was 
performed with standard antibiograms [12]. Screening 
for the expression of extended-spectrum p-lactamases 
(ESBLs) was carried out by the double disk synergy 
test (DDST) using disks containing 20 pg amoxycillin 
plus 10 pg clavulanate as described previously [13]. The 
MICs of AMC, ampicillin, cephalothin, cefoxitin and 
cefiazidime were determined by the E-test according 
to the instructions of the manufacturer (AB BioDisk, 
Solna, Sweden). Transfer of resistance to AMC was 
attempted by conjugation as described previously, using 
as a recipient the rifampicin-resistant E. coli strain 
26R793 [14]. The selective medmm contained rifain- 
picin (50 mg/L) and either ampicillin (40 mg/L) or 
AMC (2:l) (10 mg/L). 
Preparation of p-lactamase extracts 
P-Lactamase preparations were obtained by ultra- 
sonic treatment of bacterial mid-log-phase cultures in 
tryptone-soya broth. Enzymatic extracts were clarified 
by ultracentrifugation, treated with streptomycin sulfate 
to precipitate the nucleic acids and dialyzed against 
phosphate buffer (50 mM, pH 7). The protein content 
was determined with a protein assay kit (Bio-Rad 
Laboratories, CA). 
Quantitation of p-lactamases 
Quantitation of p-lactamase activity was performed 
by spectrophotometry using nitrocefin (Oxoid Ltd, 
Basingstoke, UK) as substrate [15]. P-Lactamase activity 
was expressed as units (U) (1 unit was the amount of 
enzyme hydrolyzing 1 nmol of nitrocefin per min per 
mg of protein). 
0-Lactamase hydrolysis and inhibition studies 
Maximum hydrolysis rates of penicillin G, ampicillin, 
cloxacillin and cephalothin by p-lactamase preparations 
were determined by UV spectrophotometry. Inhibition 
of nitrocefin hydrolysis by clavulanic acid and ICjo 
values were determined as described previously [8]. 
lsoelectric focusing 
Isoelectric focusing (IEF) of P-lactamases was carried 
out in polyacrylamide gels containing ampholytes 
covering a pH range from 3.5 to 10 (Pharmacia-LKB, 
Uppsala, Sweden). P-Lactamases were visualized with 
nitrocefin. 
RESULTS 
Thirty-two of the 100 E.  coli isolates were resistant to 
ampicillin. Eight were also resistant to AMC, with MIC 
values 2 32 mg/L; 11 isolates were allocated to the 
intermediate category of susceptibility to AMC, with 
MIC values ranging from 4 to 16 mg/L. All strains in 
the intermediate category were resistant to cephalothin. 
Among the eight AMC-resistant isolates, one was 
susceptible to cephalothin. None of the examined 
isolates was resistant to either cefoxitin or ceftazidime. 
MICs of p-lactams are presented in Tables 1 and 2. 
None of the 100 examined isolates was found to be 
DDST positive. 
Quantitative determination of the (3-lactamase 
content showed that seven of the eight AMC-resistant 
isolates produced at least 16-fold higher amounts of the 
enzyme(s) than the susceptible control isolates. This, 
taken together with the finding that upon IEF only a 
Table 1 Susceptibility of 100 E. coli clinical isolates to 
selected p-lactam antibiotics 
0.5 to >256 AMP 2 >256 
AMC 1.5 16 0.5-64 
CF 8 32 0.5-96 
FOX 4 4 1-12 
CAZ 0.06 0.1 0.03-0.2 
’AMAMP, ampicillin; AMC, amoxyciUin/clavulanate (ratio 2: 1); 
CF, cephalothin; FOX, cefoxitin; CAZ, cefiazidime. 
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p-lactamase band that focused at 5.4 was detected 
(Figure 1, lanes 2 and 3), suggests that resistance to 
AMC was due to TEM-1 overproduction; as expected, 
the latter strains were resistant to cephalothin. Elevated 
expression of TEM-1, albeit at  lower levels, was 
also found in the 11 E. coli isolates with decreased 
susceptibility to AMC. There was good agreement 
between the levels of TEM-1 production and the AMC 
MIC values. Resistance to AMC in the isolate Ec-R3 
that produced relatively low levels of (3-lactamase 
seemed to be due to the presence of an enzyme, 
presumably OXA-1, with an isoelectric point equal to 
7.4 (Figure 1, lane 4) and able to hydrolyze cloxacillin. 
The fact that Ec-R3 was susceptible to cephalothin 
supports the notion that the detected (3-lactamase 
belonged to the OXA family. 
None of the seven AMC-resistant TEM-1 over- 
producers was able to transfer its resistance phenotype 
to E. coli recipients with the conjugation procedure 
employed. Clavulanate-resistant TEM enzymes (con- 
ventionally named IRT (3-lactamases) were not detected 
in the sample of E. coli isolates examined here. The 
clavulanate ICSO values for the (3-lactamase extracts 
derived fiom the seven individual AMC-resistant TEM- 
producing strains ranged from 0.069 to 0.092 pM. 
None of these values differed more than 15% fioni the 
ICSO for the control TEM-1 enzyme (IC50=0.08 pM). 
The absence of inhibitor-resistant TEM p-lactamases 
has also been noticed in AMC-resistant E. coli isolates 
from Greek hospitals (Tselentis and Skoulika, un- 
published observations). It is likely that IRT enzymes 
occur sporadically on non-self-transmissible plasmids 
and therefore cannot be spread. As can be shown from 
the (3-lactam resistance phenotypes and the analysis of 
P-lactamase content, plasmids that code for extended- 
spectrum enzymes of the SHV and TEM families or 
for class C cephalosporinases were not present in 
1 2 3  4 5  
- 9.4 
Figure 1 Isoelectric focusing of p-lactamase preparations 
from the E. coli strains Ec-R1, Ec-R2 and Ec-R3 (lanes 2 
to 4). Standard P-lactamases and their isoelectric points are 
in lanes 1 and 5. 
the sample of E. coli examined here. Such plasmids, 
however, are frequently encountered in the entero- 
bacteria isolated in Greek hospitals [16]. 
CONCLUSIONS 
The salient features of this work are as follows. The 
frequency of resistance to ampicillin among E. coli 
isolated in the Greek community is high. This resis- 
tance is mostly due to production of the common 
TEM-1 plasmid-mediated p-lactamase. Thus, penicillins 
and narrow-spectrum cephalosporins are not viable 
choices fNor the treatment of community-acquired 
E. coli infections. The intensive use of Ah4C has led to 
the selection of resistant E. coli strains in Greece at a 
relatively high frequency (8%). Comparable frequencies 
of resistance to AMC (6-15%) have been observed 
Table 2 P-Lactam MIC values and P-lactamase content of three representative strains resistant to AMC and two strains with 
decreased susceptibihty 
MIC (mg/L) p-Lactamase content 
Stram AMP AMC CF FOX CAZ PI UNtS 
Ec-S1 1.5 1.5 4 2 0.03 - - 
Ec-S5 256 4 16 4 0.1 5.4 68 
Ec-I 1 a > 256 8 32 3 0.03 5.4 350 
Ec-I2 > 256 12 32 8 0.06 5.4 377 
Ec-R1 > 256 48 64 4 0.1 5.4 1254 
Ec-R2 > 256 64 96 3 0.06 5.4 2110 
Ec-R3 96 24 8 4 0.06 7.4 108 
a The designation ‘I’ denotes strains of the intermediate category of susceptibility 
Two AMC-susceptible E. coli strains, one lacking detectable p-lactamase activity (Ec-S1) and the low-level TEM-1 producer 
Ec-S5, were used as controls. Abbreviations for p-lactams are as in Table 1. 
AMC-resistant strains were designated as ‘K’. 
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recently among the E.  coli strains isolated in Athens 
hospitals (WHO-Net Study Group, unpublished obser- 
vations). Trends of resistance to AMC must be 
monitored at  least for some community-acquired 
common pathogens such as E. coli. 
There are also some additional conclusions that 
can be drawn from this work. Plasmids coding for 
overexpression of TEM-1 appeared to be unable to self- 
transmit. It has been shown that AMC resistance in 
E .  coli can be due to the acquisition of small plasmids 
encoding TEM-1 [17]. It is likely that such small 
plasmids lack tra genes and are not conjugative. O n  the 
other hand, their size and other characteristics may help 
the bacterial host to accommodate them at high copy 
number. The absence of plasmid-mediated ESBLs and 
class C enzymes indicates that the nosocomial flora 
rarely 'escapes' to the community or else that it cannot 
become established due to the lack of the appropriate 
selection pressure. 
There are no previous accounts of the frequency of 
AMC-resistant E. coli in the Greek community. Thus, 
at  present, the trends of resistance to AMC and the 
possible relationship between the incidence of resis- 
tance to AMC and the consumption of penicillin- 
inhibitor combinations cannot be estimated. It must 
be noted that such a relation i s  not necessarily linear, 
particularly in the community. Emergence and dis- 
semination of bacterial clones resistant to antibiotics are 
controlled by a variety of heterogeneous factors and 
must be studied on a case-to-case basis. 
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